Play Audio Clip Listen to audio clip.
“I think it’s a home run and something that’s really going to fly the moment it’s available.”
— Dr. Thomas Whelan of The Whelan & Company Associates on the use of the new antiviral medicine to help people with not only Ebola and Marburg viruses, but also the detection of malaria and dengue virus
Medical reporters and medical scientists take the unprecedented step of offering FDA-approved treatment options to people impacted by the deadly Marburg and Ebola outbreaks.
While Marburg, an Ebola-like virus, was identified in the 1960s, the speed at which it has developed into a worldwide epidemic of sorts is unnerving because the most common side effects of the two specific antiviral drugs, ZMapp and Mapp Biopharmaceutical have already been seen in survivors. In addition, the use of these drugs is limited. Doctors recommend people with Ebola or Marburg, or any viral illness, not take these drugs if experiencing severe side effects.
— Kate Kearney of The Washington Post on where the U.S. is with its response to the Marburg outbreak